Story perspectives

Ten New Antibodies Block EBV; One Stops Infection in Mice

5/3/2026

Summary

Story summary

U.S. researchers at Fred Hutchinson Cancer Center and the University of Washington identified ten antibodies that block EBV infection.
The set includes two gp350-targeting and eight gp42-targeting antibodies.
In mice with human-like immune systems, one gp42 antibody prevented EBV infection, showing it can block viral entry into B cells.
Researchers plan human safety testing and clinical trials, noting the antibodies may reduce post-transplant lymphoproliferative disorders, per Cell Reports Medicine.

1 of 1

Story summary

U.S. researchers at Fred Hutchinson Cancer Center and the University of Washington identified ten antibodies that block EBV infection.
The set includes two gp350-targeting and eight gp42-targeting antibodies.
In mice with human-like immune systems, one gp42 antibody prevented EBV infection, showing it can block viral entry into B cells.
Researchers plan human safety testing and clinical trials, noting the antibodies may reduce post-transplant lymphoproliferative disorders, per Cell Reports Medicine.